HERON THERAPEUTICS, INC. /DE/ (HRTX) Selling and Marketing Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Selling and Marketing Expense history and growth rate from 2015 to 2024.
  • Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the quarter ending March 31, 2024 was $11.4 M, a 45.9% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the twelve months ending March 31, 2024 was $57.9 M, a 27.8% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2023 was $67.6 M, a 18% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2022 was $82.5 M, a 5.35% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2021 was $87.2 M, a 36.5% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $57.9 M $11.4 M -$9.71 M -45.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $67.6 M $12.3 M -$5.45 M -30.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $73.1 M $13 M -$5.42 M -29.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $78.5 M $21.2 M -$1.73 M -7.56% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $80.2 M $21.2 M -$2.27 M -9.68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $82.5 M $17.8 M -$6.71 M -27.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $89.2 M $18.4 M -$6.83 M -27.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $96.1 M $22.9 M +$688 K +3.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $95.4 M $23.4 M +$8.19 M +53.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $87.2 M $24.5 M +$8.93 M +57.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $78.2 M $25.2 M +$12.7 M +101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $65.6 M $22.3 M +$6.66 M +42.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $58.9 M $15.2 M -$4.96 M -24.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $63.9 M $15.6 M -$4.87 M -23.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 $68.7 M $12.5 M -$4.46 M -26.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $73.2 M $15.6 M -$8.06 M -34.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $81.2 M $20.2 M -$8.52 M -29.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $89.8 M $20.4 M +$463 K +2.32% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $89.3 M $17 M +$696 K +4.28% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 $88.6 M $23.6 M +$9.12 M +62.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 $79.5 M $28.7 M +$14.9 M +108% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 $64.6 M $20 M +$3.27 M +19.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $61.3 M $16.3 M +$2.75 M +20.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 $58.6 M $14.5 M -$239 K -1.62% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $58.8 M $13.8 M +$2.22 M +19.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $56.6 M $16.7 M +$4.03 M +31.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 $52.6 M $13.5 M +$1.37 M +11.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 $51.2 M $14.8 M +$3.76 M +34.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 $47.4 M $11.6 M -$234 K -1.97% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q4 2016 $47.7 M $12.7 M +$4.45 M +54.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $43.2 M $12.2 M +$8.04 M +195% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 $35.2 M $11 M +$8.25 M +299% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $26.9 M $11.9 M +$9.58 M +422% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $17.3 M $8.2 M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 $4.12 M Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $2.76 M Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $2.27 M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.